
BAW2881
CAS No. 861875-60-7
BAW2881 ( BAW2881 | BAW-2881 | BAW 2881 )
产品货号. M17624 CAS No. 861875-60-7
BAW2881 是一种有效的选择性 VEGFR 抑制剂(血管内皮生长因子受体酪氨酸激酶抑制剂),具有抑制慢性和急性皮肤炎症的活性。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥348 | 有现货 |
![]() ![]() |
5MG | ¥551 | 有现货 |
![]() ![]() |
10MG | ¥948 | 有现货 |
![]() ![]() |
25MG | ¥1806 | 有现货 |
![]() ![]() |
50MG | ¥2916 | 有现货 |
![]() ![]() |
100MG | ¥4228 | 有现货 |
![]() ![]() |
500MG | ¥9477 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称BAW2881
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BAW2881 是一种有效的选择性 VEGFR 抑制剂(血管内皮生长因子受体酪氨酸激酶抑制剂),具有抑制慢性和急性皮肤炎症的活性。
-
产品描述BAW2881 is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit chronic and acute skin inflammation. NVP-BAW2881 inhibited proliferation, migration, and tube formation by human umbilical vein endothelial cells and lymphatic endothelial cells in vitro. NVP-BAW2881 reduced the number of blood and lymphatic vessels and infiltrating leukocytes in the skin, and normalized the epidermal architecture. NVP-BAW2881 also displayed strong anti-inflammatory effects in models of acute inflammation; pretreatment with topical NVP-BAW2881 significantly inhibited VEGF-A-induced vascular permeability in the skin of pigs and mice.
-
体外实验The VEGF-driven cellular receptor autophosphorylation in CHO cells of BAW2881 is inhibited with an IC50 of 4 nM. BAW2881 inhibits a limited number of kinases including c-RAF, B-RAF, RET, ABL, and TIE-2 at sub-μM IC50s. NVP-BAW2881 is highly selective for VEGFR, although it also demonstrates activity against Tie2 (IC50=650 nM) and RET (IC50=410 nM). The IC50 values of NVP-BAW2881 toward a wide panel of other kinases are >10 μM. NVP-BAW2881 inhibits VEGF-A-induced phosphorylation of VEGFR-2 in HUVECs and in VEGFR-2-transfected Chinese hamster ovary cells, with IC50 values of 2.9 and 4.2 nM, respectively.
-
体内实验In a transgenic mouse model of psoriasis, NVP-BAW2881 reduces the number of blood and lymphatic vessels and infiltrating leukocytes in the skin, and normalized the epidermal architecture. NVP-BAW2881 also displays strong anti-inflammatory effects in models of acute inflammation; pretreatment with topical NVP-BAW2881 significantly inhibits VEGF-A-induced vascular permeability in the skin of pigs and mice.
-
同义词BAW2881 | BAW-2881 | BAW 2881
-
通路Others
-
靶点Other Targets
-
受体c-Abl| B-Raf (V599E)| C-Raf-1| hVEGFR2
-
研究领域Endocrinology
-
适应症——
化学信息
-
CAS Number861875-60-7
-
分子量424.38
-
分子式C22H15F3N4O2
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 33 mg/mL; 77.76 mM
-
SMILESO=C(c1c2ccc(Oc3nc(N)ncc3)cc2ccc1)Nc1cccc(C(F)(F)F)c1
-
化学全称6-((2-aminopyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Halin C, et al. Am J Pathol. 2008 Jul;173(1):265-77.
产品手册




关联产品
-
Vazegepant HCl
Vazegepant 是第一个用于急性治疗偏头痛的鼻内 gepant,并已宣布进行积极的 II/III 期研究。
-
C14TKL-1 TFA
Endogenous human tachykinin-like peptide and potent agonist for NK1 receptors (EC50 = 1 nM).
-
Allisartan Isoproxil
Allisartan Isoproxil 是一种血管紧张素 II 受体拮抗剂,用于治疗轻度至中度原发性高血压。